E. Lin
About
E. Lin is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine.
According to data from OpenAlex, E. Lin has authored 35 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 12 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in E. Lin's work include Colorectal Cancer Treatments and Studies (11 papers), Cancer Treatment and Pharmacology (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). E. Lin is often cited by papers focused on Colorectal Cancer Treatments and Studies (11 papers), Cancer Treatment and Pharmacology (7 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). E. Lin collaborates with scholars based in United States, Germany and Taiwan. E. Lin's co-authors include Scott Kopetz, Jean‐Pierre J. Issa, Lanlan Shen, Saira Ahmed, Yutaka Kondo, Yi Guo, Tzyy‐Wen Chiou, Horng‐Jyh Harn, Yu-Shuan Chen and James L. Abbruzzese and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.
In The Last Decade
E. Lin
34 papers receiving 2.0k citations
Peers
E. Lin
Irina A. Lubensky United States
Shioto Suzuki Japan
Florence Coulet France
Kerrington D. Smith United States
Adrian Murphy United States
Francesca Negri Italy
Akishi Ooi Japan
H Arnholdt Germany
Hiroshi Ida Japan
Pramila Ramani United Kingdom
Citations per year, relative to E. Lin E. Lin (= 1×)
peers
Irina A. Lubensky
Countries citing papers authored by E. Lin
Since
Specialization
Citations
This map shows the geographic impact of E. Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Lin more than expected).
Fields of papers citing papers by E. Lin
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by E. Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Lin. The network helps show where E. Lin may publish in the future.
Co-authorship network of co-authors of E. Lin
This figure shows the co-authorship network connecting the top 25 collaborators of E. Lin. A scholar is included among the top collaborators of E. Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Lin. E. Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Lin, E., et al.. (2024). Engineered Exosomes Containing microRNA-29b-2 and Targeting the Somatostatin Receptor Reduce Presenilin 1 Expression and Decrease the β-Amyloid Accumulation in the Brains of Mice with Alzheimer’s Disease. International Journal of Nanomedicine. Volume 19. 4977–4994.
2.
Harn, Horng‐Jyh, Yu-Shuan Chen, E. Lin, & Tzyy‐Wen Chiou. (2019). Exosomes in clinical trial and their production in compliance with good manufacturing practice. Tzu Chi Medical Journal. 32(2). 113–113.
3.
Li, Xinqun, Ya’an Kang, Xavier Chopin‐Laly, et al.. (2014). Extracellular Lumican Inhibits Pancreatic Cancer Cell Growth and Is Associated with Prolonged Survival after Surgery. Clinical Cancer Research. 20(24). 6529–6540.
4.
Lieu, Christopher H., Hai T. Tran, Zhi-Qin Jiang, et al.. (2013). The Association of Alternate VEGF Ligands with Resistance to Anti-VEGF Therapy in Metastatic Colorectal Cancer. PLoS ONE. 8(10). e77117–e77117.
5.
Erdem, Özlem, et al.. (2011). Dermatofibrosarcoma Protuberans Treated With Wide Local Excision and Followed at a Cancer Hospital: Prognostic Significance of Clinicopathologic Variables. American Journal of Dermatopathology. 34(1). 24–34.
6.
Katz, Matthew H. G., Robert A. Wolff, Christopher H. Crane, et al.. (2011). Survival and Quality of Life of Patients with Resected Pancreatic Adenocarcinoma Treated with Adjuvant Interferon-Based Chemoradiation: A Phase II Trial. Annals of Surgical Oncology. 18(13). 3615–3622.
7.
Kaseb, Ahmed O., James L. Abbruzzese, Jean‐Nicolas Vauthey, et al.. (2011). I-CLIP: Improved Stratification of Advanced Hepatocellular Carcinoma Patients by Integrating Plasma IGF-1 into CLIP Score. Oncology. 80(5-6). 373–381.
8.
Konoplev, Sergej, E. Lin, S. Faderl, et al.. (2011). Hypocellular acute myeloid leukemia in adults: analysis of the clinical outcome of 123 patients. Haematologica. 97(2). 235–240.
9.
Fogelman, David R., Mehrdad Jafari, Gauri R. Varadhachary, et al.. (2011). Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial. Cancer Chemotherapy and Pharmacology. 68(6). 1431–1438.
10.
Patel, Dina, E. Lin, Harmeet Kaur, et al.. (2011). Chemotherapy outcomes for the treatment of unresectable intrahepatic and hilar cholangiocarcinoma: a retrospective analysis.. PubMed. 4(5-6). 155–60.
11.
Wierda, William G., E. Lin, Shao-Qing Kuang, et al.. (2010). Genome-wide DNA methylation profiling of chronic lymphocytic leukemia allows identification of epigenetically repressed molecular pathways with clinical impact. Epigenetics. 5(6). 499–508.
12.
Overman, Michael J., Scott Kopetz, E. Lin, James L. Abbruzzese, & Robert A. Wolff. (2010). Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine. Acta Oncologica. 49(4). 474–479.
13.
Kaseb, Ahmed O., Manal M. Hassan, E. Lin, et al.. (2010). V‐CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials. Cancer. 117(11). 2478–2488.
14.
Gregório, Sheila P., Paulo Clemente Sallet, Kim‐Anh Do, et al.. (2008). Polymorphisms in genes involved in neurodevelopment may be associated with altered brain morphology in schizophrenia: Preliminary evidence. Psychiatry Research. 165(1-2). 1–9.
15.
Caraway, Nancy P., Elizabeth Thomas, Abha Khanna, et al.. (2008). Chromosomal abnormalities detected by multicolor fluorescence in situ hybridization in fine-needle aspirates from patients with small lymphocytic lymphoma are useful for predicting survival. Cancer. 114(5). 315–322.
16.
Curley, Steven A., Brenda F. Kurland, Sunil Krishnan, et al.. (2007). Long-term maintenance capecitabine and celecoxib improved clinical outcomes by targeting colorectal cancer micrometastasis. Journal of Clinical Oncology. 25(18_suppl). 14513–14513.
17.
Başer, Sevin, Vickie R. Shannon, Georgie A. Eapen, et al.. (2006). Smoking Cessation After Diagnosis of Lung Cancer Is Associated With a Beneficial Effect on Performance Status. CHEST Journal. 130(6). 1784–1790.
18.
Kopetz, Scott, James L. Abbruzzese, Cathy Eng, et al.. (2006). Preliminary results from a phase II study of infusional 5-FU, leucovorin, and irinotecan (FOLFIRI) plus bevacizumab as first-line treatment for metastatic colorectal cancer (mCRC). Journal of Clinical Oncology. 24(18_suppl). 3579–3579.
19.
Başer, Sevin, Vickie R. Shannon, Georgie A. Eapen, et al.. (2006). Pulmonary Dysfunction as a Major Cause of Inoperability Among Patients with Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 7(5). 344–349.
20.
Das, Prajnan, E. Lin, S. Bhatia, et al.. (2005). Neoadjuvant Chemoradiation with Capecitabine Versus Infusional 5-fluorouracil (5-FU) for Locally Advanced Rectal Cancer: A Matched Pair Analysis. International Journal of Radiation Oncology*Biology*Physics. 63. S164–S164.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Irina A. Lubensky Breakdown of academic impact, for papers by Shioto Suzuki Breakdown of academic impact, for papers by Florence Coulet Breakdown of academic impact, for papers by Kerrington D. Smith Breakdown of academic impact, for papers by Adrian Murphy Breakdown of academic impact, for papers by Francesca Negri Breakdown of academic impact, for papers by Akishi Ooi Breakdown of academic impact, for papers by H Arnholdt Breakdown of academic impact, for papers by Hiroshi Ida Breakdown of academic impact, for papers by Pramila Ramani